
|Articles|May 15, 2012
MedPAC Recommendations
In this segment the panel talks about the consequences SGR might have on primary care practices. They discuss what the efficient costs of production are for the healthcare we aim to deliver.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
60% of US Women Face Barriers to Postpartum, Mental Health Care
4
Counseling Vitiligo Patients on Time to Repigmentation
5
